Key result
Prevention of venous thromboembolic events in acute stroke is guided by established clinical trial evidence and current UK clinical practice recommendations to reduce morbidity and mortality.
This article reviews the clinical trial evidence and UK recommendations for preventing venous thromboembolic events in patients with acute stroke.
Answers are grounded in this paper and cite their sources.
Supports current UK VTE prevention practices in acute stroke; leaves open refinement via updated trials in evolving populations.
Venous thromboembolic events are a major cause of morbidity and mortality in patients with acute stroke and their prevention presents a significant challenge. This article outlines the clinical trial evidence for prevention of venous thromboembolic events in acute stroke, and the current UK clinical practice recommendations.
No takes yet. Share an insight, caveat, or question.
Joseph Anderson (2015) studied this question. Prevention of venous thromboembolic events in acute stroke is guided by established clinical trial evidence and current UK clinical practice recommendations to reduce morbidity and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: